ER
Eiry Roberts (Chief Medical Officer) filed 3 Form 4 reports in the past 24 months (0 purchases, 3 sales), most often in Neurocrine Biosciences, Inc. (NBIX). The largest single filing was $223K of NBIX (1,457 sh × $152.80, as filed), executed Jan 31 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$469K
shares × price, as filed
Last traded
Feb 13 2025
Filed Feb 14 2025
Median ADV $194.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $469K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 24 months
Most traded names
NBIXRecent filings
NBIXSALE
Neurocrine Biosciences, Inc.
View filing →
$130K1,114 sh × $116.90
Exec Feb 13 2025
Filed Feb 14 2025 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. View filing → $116K
980 sh × $118.22
Exec Feb 10 2025
Filed Feb 12 2025 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. View filing → $223K
1,457 sh × $152.80
Exec Jan 31 2025
Filed Feb 4 2025 · 5:30 PM ET